• Release date: July 23, 2020

• Expiration date: July 23, 2023

• Estimated time to complete activity: 4.5 hours

• Jointly provided by Postgraduate Institute for Medicine and CME Science

Course Description

This course is designed to provide the tools for participants to enhance interpretation skills utilizing the latest imaging technologies. Lectures and cases will cover evidence-based practice techniques and protocols for improved diagnostic accuracy in abdominal and chest imaging.

Educational Objectives

At the conclusion of this activity, participants should better be able to:

Describe recent advances and techniques in abdominal imaging.

Develop differential diagnosis that relates to the pertinent imaging and clinically relevant findings for each of the cases covered in this course.

Utilize advanced MDCT for abdominal imaging.

Faculty

Gabriela Gayer, M.D.


• Professor of Radiology | Sackler Faculty of Medicine

• Professor of Radiology | Tel Aviv University

• Professor of Radiology | Stanford University School of Medicine

Gabriela Gayer MD, is a clinical professor at the Department of Radiology at the Stanford University Medical Center, Stanford, California, USA. She also works at the Sheba Medical Center, affiliated to the Tel-Aviv University, in Israel, where she graduated from the Sackler Faculty of Medicine in 1986.

She is a passionate radiologist and an active researcher in the field of abdominal CT, where her main research interests are the acute abdomen, the postoperative abdomen and iatrogenic complications. Dr. Gayer is the author of more than 120 articles and serves as a co-editor of Seminars in Ultrasound CT and MRI since 2005, a task she finds inspiring and stimulating.

Pricing


$495

Abdominal Imaging - Gabriela Gayer, M.D.

CME Science


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CME Science. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

The faculty members have nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The CME Science planners and managers have nothing to disclose.

Method of Participation and Request for Credit

During the period July 23, 2020 through December 31, 2021, participants must read the learning objectives and faculty disclosures and study the educational activity. 

Media

Internet

Computer System Requirements

Any online accessible device.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Computer System Requirements

Any online accessible device.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.